HopeStage
Study directory

Schizophrenia studies

Schizophrenia can affect how a person perceives reality, thinks and feels, sometimes involving hearing voices or holding unusual beliefs.

Back to overview
More filters: keywords, city, remote
453studies shown
Showing 301-312 of 453
Drug study icon
RecruitingNCT07105111

Effectiveness of valbenazine in adults with tardive dyskinesia

Official study title

A Phase 4, Open-Label Study to Evaluate the Efficacy of Valbenazine on Clinician- and Patient-Reported Outcomes in Patients With Tardive Dyskinesia (TD) Who Remain Symptomatic While on Deutetrabenazine or After Discontinuing Prior TD Treatment With a Vesicular Monoamine Transporter 2 (VMAT2) Inhibitor

Multiple locations, including Bryant
Schizophrenia, Depression, ...Medication studyAges 18+
Countries
United States
Sponsor
Neurocrine Biosciences (Biotech company)
Behavioral study icon
RecruitingNCT06898879

Enhancing Veteran-Clinical Collaboration in VA PRRCs

Official study title

Enhancing Veteran-Clinical Collaboration in VA Psychosocial Rehabilitation and Recovery Centers

In Albuquerque
Schizophrenia, Depression, ...Behavioural studyAges 18+
Countries
United States
Sponsor
VA Office of Research and Development (Government agency)
Drug study icon
RecruitingNCT06740890

Exercise and Olanzapine-samidorphan

Official study title

A Proof of Concept Study of Time Limited Exercise Plus Olanzapine-samidorphan for the Prevention of Early Weight Gain

In New York
Schizophrenia, BipolarityMedication studyAges 18–65
Countries
United States
Sponsor
New York State Psychiatric Institute
Other study type icon
RecruitingNCT07234708

Feeling Safe Study

Official study title

Feeling Safe: Feasibility and Acceptability Study Evaluating a New Psychological Intervention for People With Psychosis and Positive Delusional Symptoms

In Barcelona
SchizophreniaInterventional studyAges 18+
Countries
Spain
Sponsor
Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau
Behavioral study icon
RecruitingNCT06286202

Cognitive-remediation program or standard rehabilitation for serious mental health conditions

About this title

Integrative Neuro-social Cognitive Strategy Programme for Instilling REcovery (INSPIRE) a Community-Based Cognitive Remediation Trial

Read the official source — NCT06286202
Official study title

Integrative Neuro-social Cognitive Strategy Programme for Instilling REcovery (INSPIRE): a Community-Based Cognitive Remediation Trial

In Singapore
SchizophreniaBehavioural studyAges 21–60
Countries
Singapore
Sponsor
Singapore Institute of Technology
Behavioral study icon
RecruitingNCT07085923

Norwegian Mental Illness Heart Health Study

Official study title

Dietary Counselling And Exercise To Combat Cardiovascular Disease Risk In Norwegian Patients With A Severe Mental Illness

In Oslo
Schizophrenia, BipolarityBehavioural studyAges 25–70
Countries
Norway
Sponsor
Madeleine Elisabeth Angelsen
Drug study icon
RecruitingACTRN12605000516684

Switching to aripiprazole from other second-generation antipsychotics.

Official study title

A randomised phase IV study to compare two rates of dosage tapering, when switching patients to aripiprazole from other atypical antipsychotics for the treatment of schizophrenia and schizoaffective disorder

Location not clearly listed
SchizophreniaInterventional study
Countries
Sponsor
Bristol Meyers Squibb Pharmaceuticals
Behavioral study icon
RecruitingNCT06005766

Group metacognitive skills training for people receiving forensic psychiatric care

About this title

The Efficacy of Metacognitive Skills Training in the Context of Forensic Psychiatric Care

Read the official source — NCT06005766
Official study title

Does Group-Based Metacognitive Skills Training Reduce Jumping to Conclusions Bias of Patients With Psychotic Disorders in the Context of Forensic Psychiatric Care

In Vaasa
Schizophrenia, DepressionBehavioural studyAges 18+
Countries
Finland
Sponsor
University of Jyvaskyla

Registry coverage

We gather information about mental health clinical trials from the public registries we index. Coverage is still expanding, so some studies may not appear yet.